Steven Nissen: The Hidden Agenda Behind The FDA's New Avandia Hearings

Is the FDA holding a two-day panel with the goal of making its leadership look better with regard to the withdrawn diabetes drug? The cardiologist who blew the whistle on Avandia wants to know.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news